US Patent 10077249 Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
Patent 10077249 was granted and assigned to Global Blood Therapeutics on September, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 11, 2017
Date of Patent
September 18, 2018
Patent Applicant
Patent Application Number
15593198
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10077249 Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
